logo
Eris Lifesciences Ltd.
13 Jan 2021, 12:00AM
1675.90
-1.37%
Prabhudas Lilladhar
IPM growth recovered in Dec-20 to 8.5% after weak Nov-20, due to festive season and fears related to lockdown. The key reasons for growth in Dec-20 (as from Nov-20 onwards) are (i) MRs back on field with full force and (ii) marketing activities reaching pre-COVID levels. Digital marketing continues to be an integral part of marketing activities, which actually started as a cost...
Promoters unpledged 1.58% of shares in last quarter. Total pledge stands at 16.93% of promoter holdings
More from Eris Lifesciences Ltd.
Recommended